Aurinia Pharmaceuticals Inc. (AUPH) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $32.66M | +15.6% |
| 2024 | $28.25M | +99.7% |
| 2023 | $14.15M | +149.8% |
| 2022 | $5.66M | +419.2% |
| 2021 | $1.09M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $32.66M | +15.6% |
| 2024 | $28.25M | +99.7% |
| 2023 | $14.15M | +149.8% |
| 2022 | $5.66M | +419.2% |
| 2021 | $1.09M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |